Moya-Guzmán MJ, de Solminihac J, Carrasco-Loncharic T, Kaehne T & Pino-Lagos K — Frontiers in Immunology, 2026
This study investigates small extracellular vesicles (sEVs) released by different subsets of CD4+FoxP3+ regulatory T cells (Tregs) and their potential contribution to immune suppression. Tregs are essential for maintaining immune tolerance and can regulate immune responses through several mechanisms, including anti-inflammatory cytokines, inhibitory molecules, adenosine production, cytotoxic pathways, and extracellular vesicles. While sEV-mediated suppression has been studied mainly in natural Tregs (nTregs), considerably less is known about vesicles produced by Tregs induced in vitro.
The authors compared three Treg populations: natural Tregs (nTregs), TGF-β-induced Tregs (iTregs), and Tregs generated with TGF-β plus all-trans retinoic acid (RATregs). Their sEVs were characterized by nanoparticle tracking, protein markers and functional assays, while mass spectrometry-based proteomics was used to investigate their molecular cargo.
All three Treg subsets produced sEVs with typical vesicular characteristics and the canonical marker Alix. However, RATregs generated the largest number of vesicles, while some differences in particle-size distribution were observed among the populations. Figure 1 shows that most particles produced by the three Treg subsets were within the 51–250 nm range and confirms differences in sEV production among the cell types.
Functionally, sEVs derived from all three Treg subsets were able to suppress CD4+ and CD8+ T-cell proliferation in vitro in a dose-dependent manner. Natural Treg-derived vesicles displayed the strongest suppressive effect, reaching approximately 100% suppression of CD4+ T-cell proliferation at the highest tested dose (10⁸ particles). At the same dose, iTreg- and RATreg-derived sEVs produced approximately 60% and 70% suppression, respectively. The lowest tested dose was ineffective. Cytokine measurements for IFN-γ, IL-17 and IL-10 were too variable to support definitive conclusions.
A particularly important finding was the association between these vesicles and T-cell death. In CD4+ T cells, activation alone resulted in approximately 5% early apoptosis, whereas exposure to sEVs from nTregs or RATregs increased this proportion to approximately 12%. iTreg-derived vesicles did not produce the same enhancement. The experiments also ruled out the possibility that this effect simply resulted from apoptotic bodies released by dying Tregs during culture. These observations suggest that Treg-derived sEVs may suppress immune responses not only by reducing proliferation but also by promoting cytotoxicity in target cells.
Proteomic analysis provided a potential molecular explanation for this effect. The researchers identified 201 proteins in nTreg-derived sEVs, 736 in iTreg-derived sEVs and 631 in RATreg-derived sEVs, with 163 proteins shared by all three groups. Among the common proteins were molecules associated with Treg biology and immune regulation, including Apolipoprotein AI, Integrin β2, Lactate Dehydrogenase-A, Thrombospondin 1 and Transferrin Receptor.
More importantly, the proteomic profiles contained several proteins associated with cell-death pathways. These included Annexin 6, Integrin β2, Thrombospondin-1, Gasdermin-3, Perforin-1, Granzyme C, Nme1, Vdac, Granzyme A, Granzyme B and Serglycin. As illustrated in Figure 4, these proteins formed distinct clusters depending on the Treg source, suggesting that the molecular composition—and consequently the biological effects—of sEVs varies among Treg subsets.
The authors therefore propose that cell death may represent an additional mechanism through which Treg-derived extracellular vesicles suppress T-cell responses. One possibility is that effector T cells internalize the vesicles and thereby acquire molecules capable of initiating apoptotic pathways; alternatively, the vesicles may act indirectly on other immune cells that subsequently induce T-cell death. The precise mechanism remains unresolved.
The study has several limitations, including variability in cytokine measurements, the absence of a defined molecular pathway explaining sEV-induced cell death, and the lack of an in vivo model to establish the physiological relevance of the findings. Nevertheless, the results broaden the understanding of Treg-mediated immune regulation by identifying sEV-associated cytotoxicity as a potential suppressive mechanism.
Overall, the study demonstrates that natural and in vitro-induced Treg subsets release functionally suppressive sEVs with distinct protein compositions. The presence of apoptosis- and cytotoxicity-related proteins suggests that extracellular vesicles may contribute to Treg-mediated immune suppression partly by promoting target-cell death. Because iTregs and RATregs can be generated more readily than natural Tregs, their sEVs may also represent promising candidates for future cell-free immunoregulatory therapies, although their cytotoxic effects and mechanisms will require further investigation before therapeutic application.